Read More Pharma Industry News Sino Biopharmaceutical signs $1.9bn AstraZeneca deal and expands GSK alliance Sino Biopharmaceutical signs a $1.9 billion AstraZeneca deal and expands GSK China respiratory rights. Read how 1177.HK could reshape growth. bySrinathJuly 8, 2026